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Abstract
Among mycotic diseases ofthe lung, pulmonary aspergillosis caused by aspergilloma fumigatlls is
the one encountered most frequently. An unusual case with a cystic lesion in thc lung which turned
out to be an aspergilloma is presented here.
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Introduction
Pulmonary Aspergillosis is commonly prcsent in
paticnts who are immunosuppressed orhave chronic Iljng
discases. Majority of these patients present witli
hemoptysis. Although a routine chest radiograph may
suggest the diagnosis ofaspergillosis, CTscan is the best
investigation to confirm it and plan theextentofsurgery.
Operative resseclion is the best modality of treatment
as it offers permanent cure and avoids any need fOr
antifungal therapy.
Case Report
A 30 year old lady presented with complaints of
hemoptysis for last 12 years. This was occasional i. e.
once in 3-4 months. She had no other associated
complaints like chest pain, breathlessness. There was
no history offever, nausea, vomiting, loss ofappetite or
lossofweight. She had past historyofpulmonary Koch's
12 years ago and had received a full course of
antitubercular therapy.
She was investigated for the cause of hemoptysis.
Routine blood investigations like Hemogram. blood urea,
sugar, liver function tests were within normal limits
except a raised ESR (60 mm in Ist hr.). Sputum for AFB
was negative. Chest x-ray revealed a cavity in the right
perihilar region with an eccentric soft density mass in i~
suggesting a possibility of hydatid cyst or a fungal
infection.
Bronchoscopy did not reveal any growth but fresh
bleeding was spotted from the opening of superior
segment of right lower lobe. Bronchial aspirate and
sputum were negative for AFB, malignant cells and
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Fig. 2. Showing excised specimen ofthe <tspcrgilloma.
Discussion
Aspergillosis is a fungal infection usually caused by
aspergillus fumigatus. Two forms of aspergillosis are
recognised-primaryand secondary. Secondaryoccurs in
damaged lungs or in lungsofhostwith impaired defence
mechanisms due to AIDS, malignant disease such as
leukaemia or lymphoma orto therapeutic agents such as
steroids, anti-metabolites, cytotoxic drugs, antibioticsor
other drugs causing bone marrow depression (1,2,3).
More frequently,' it occurs in chronic lung disease as a
saprophyticcoloniserofpre-existingcavities e. g. caused
by tuberculosis, bronchiectasis etc. (4,5). Aspergillomas
commonly grow in tuberculous cavities. A British
Tuberculosis Association report (4) states that
aspergillomas occur in 15% of open negative cavities
largerthan 2.5 cm with the highest incidence in cavities
ofseven to elevenyearsduration. North American series
have less incidence of tuberculosis (33%) as reported
by Faulkner and Colleagues (6) and there, aspergillosis
is seen most comonly in association with histoplasmosis
(19%),sarcoidosisand ankylosingspondylitis(7). Pleural
aspergillomas most often develop in a residual pleural
spaceafteroperation (orformerly aftercollapse therapy
;us. CT scan of the chest revealed a right sided
,riorly placed irregular thick walled cavity at hilar
,I having adependent solid component that changed
lion with change in posture. Other lung fields were
I and there was no mediastinal Iymhadenopathy
.1)
The patient was taken up for surgery after
n,esligations. A right posterolateral thoractomy
"as performed lirrough the 5th intercostal space.
The lung surface appeared normal in appearance.
On palpation, there was a thickening in the upper
poslerior part oflower lobe. Lung tissue was incised at
he site and it revealed a cyst like struCture unlike a
)datidcyst,approximately 5cm in diameter, which was
excised (Fig. 2). Hemostasis was ensured and air leaks
"ere sulured and chest was closed with an intercostal
lube drainage.Yost operative recovery was uneventful
and chest tube was removed on the 5th day. The
hislOpathology showed the removed cyst to be an
aspergilloma. Subsequently in 5 years follow-up, the
atient has had no hemoptysis and is absolutely
'l'ryrIJ!omatic.
Contrast enhanced CT scan chest showing irregular thick
walled cavity at hilar level in the posterior segment of
righllung.
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for tuberculosis) and is favoured by a bronchopleural
fistula (8).
The predominant symptoms of aspergillosis are
hemoptysis, bronchorrhoea, fever and weight loss.
Hemoptysis occurs in 50 to 80% ofpatients (1,9). It can
be so severe as to be fatal and therefore aspergillomas
are best treated surgically (10).
Diagnosis is based on repeated isolation ofthe fungus
from the sputum (II), transbronchial lavage or biopsy,
chest x-ray, CT scan, complement fixation test and
aspergillus skin test. Chest x-ray shows an air crescent
sign that is a cavitywith an eccentric shadowofa fungus
ball (mycetoma) in it (12). Similar appearance is seen
on a CT scan which is good for localisation and
determining the surgical approach (13). Differential
diagnosis includes intracavitary blood clots, liquefying
pulmonary infection and hydatid cyst (14).
Treatment of pulmonary or pleural aspergilloma is
primarily surgical. The surgical mortality is low (less
than 7%) as reported by Kilman (15), potential for cure
is excellent and the dangerofantifungal chemotherapy
is obviated. Surgery is recommended when thefollowing
criteria are satisfied (16) :-
I. Aspergilloma and underlying lung disease are
not widespread.
2. Patient has recurrent episodes ofhemoptysis or
chronic production ofpurulent sputum.
3. Patients is in good health.
Mortality rates are high (38-44%) when operatingon
symptomatic patients specially whel~ functional and
nutritional status of the patients are bad (17-19).
However, operation is advised because symptomatic
manifestations may become life threatening. A segmental
or lobar resection may be attempted only ifthe lesions
50
are confined to a single lobe and if the functl!
and nutritional status of the patient are con,i,,-
with a major surgical procedure. In all ot\
cases a pleuropneumonectomy for removal ol~,
mycetoma followed by immediate thoracoplastj
recommended (20-21). The most appropriate precedu.
recommended for aspergillus empyema is a gener
thoracoplasty (20).
In asymptomatic patients mortality rates are 10w(1~
as reported by Daly el. af. (17). Such patients shoula
undergo operation on principle. The ideal procedureil
segmental or lobar resection (20). Lobectomy is t\e
preferred procedure. Pneumonectomy has been donef~
widespread disease (1). The extent of resection of
intrapulmonaryaspergilloma dependson the severity of
the underlying lung pathologyas well as the aspergilloma
itself (22). Because of the saprophytic nature of the
organism, resection should be limited so as not to
decrease lung function but since the organism can be
invasive, a segmental orwedge resection Can sometimes
be dangerous (16).
There is .no alternative to operative treatment.
Systemic administration'of amphotericin-B or
itraconazole(23) is currently beneficial only for invasive
aspergillosis. It has a questionable action on the
mycetoma. Direct intracavitary instilIation ofantifungal
agents such as amphotericin B, sodium iodide should be
resorted toas primary therapy in patients whose general
medical status or poor pulmonary.reserve makes the
operative risk prohibitive (24).
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